Syngen Biotech Co (ROCO:8279) ROCE %: 7.75% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8279 Syngen Biotech Co Ltd ROCO:8279
89 GF Score
Price NT$88.50
GF Value NT$158.15
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Syngen Biotech Co ROCE %?

Syngen Biotech Co ROCO:8279 +1.03% 89 ROCE % is 7.75% as of Dec. 2025. GuruFocus rates ROCO:8279 with a GF Score™ of 89/100 and a GF Value™ of NT$158.15 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Syngen Biotech Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 7.75%.

Syngen Biotech Co  (ROCO:8279) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Syngen Biotech Co ROCE % Related Terms

Syngen Biotech Co ROCE % Historical Data

* Premium members only.

The historical data trend for Syngen Biotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngen Biotech Co ROCE % Chart

Syngen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.67 18.47 14.06 12.15 13.37

Syngen Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.77 12.58 18.06 17.06 7.75
ROCO:8279
89GF Score
Syngen Biotech Co Ltd ROCO:8279
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syngen Biotech Co ROCE % Calculation

Syngen Biotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=340.496/( ( (3084.594 - 520.156) + (3048.09 - 519.576) )/ 2 )
=340.496/( (2564.438+2528.514)/ 2 )
=340.496/2546.476
=13.37 %

Syngen Biotech Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=195.044/( ( (3071.58 - 564.722) + (3048.09 - 519.576) )/ 2 )
=195.044/( ( 2506.858 + 2528.514 )/ 2 )
=195.044/2517.686
=7.75 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.75% mean?
Syngen Biotech Co (ROCO:8279) has a ROCE % of 7.75% as of Dec. 2025.
Is Syngen Biotech Co's ROCE % too high?
Syngen Biotech Co's current ROCE % is 7.75%. Overall, Syngen Biotech Co has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngen Biotech Co's ROCE % compare to VRTX and REGN?
Syngen Biotech Co's ROCE % of 7.75% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Syngen Biotech Co's current ROCE % is 7.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Syngen Biotech Co (ROCO:8279) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$158.15, compared to a current price of NT$88.50 — trading 44% below its estimated fair value. The current ROCE % is 7.75%. Syngen Biotech Co's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Syngen Biotech Co (ROCO:8279), the current ROCE % is 7.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syngen Biotech Co (ROCO:8279) Overvalued in 2026?

Based on GuruFocus' analysis, Syngen Biotech Co stock appears to be undervalued. The current stock price of NT$88.50 is trading 44% below its estimated GF Value™ of NT$158.15. GuruFocus considers Syngen Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:8279:

  • ROCE %: 7.75%
  • GF Value™: NT$158.15 vs. price of NT$88.50 (44% below fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the ROCO:8279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syngen Biotech Co Business Description

Address Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.
89GF Score

Get the complete analysis for ROCO:8279

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$88.50
Price
NT$158.15
GF Value